52 related articles for article (PubMed ID: 546589)
21. The use of ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene) as a ligand for brain dopamine receptors [proceedings].
Cross AJ; Crow TJ; Owen F
Br J Pharmacol; 1979 May; 66(1):87P. PubMed ID: 454971
[No Abstract] [Full Text] [Related]
22. Dopamine and dihydroergocryptine binding to the anterior pituitary and other brain areas of the rat and sheep.
Cronin MJ; Roberts JM; Weiner RI
Endocrinology; 1978 Jul; 103(1):302-9. PubMed ID: 105889
[No Abstract] [Full Text] [Related]
23. Improved high-affinity binding of 3H-apomorphine with a subcellular membrane fraction of mammalian brain tissue.
Arana GW; Baldessarini RJ; Herschel M; Fava M
Life Sci; 1981 Jul; 29(2):121-33. PubMed ID: 6270486
[No Abstract] [Full Text] [Related]
24. Dopamine receptor supersensitivity in the corpus striatum following chronic elevation of brain gamma-aminobutyric acid.
Ferkany JW; Strong R; Enna SJ
J Neurochem; 1980 Jan; 34(1):247-9. PubMed ID: 7452243
[No Abstract] [Full Text] [Related]
25. Characterization of calf brain dopamine receptors [proceedings].
Leavens WJ; Riddall DR
Br J Pharmacol; 1979 May; 66(1):88P-89P. PubMed ID: 454972
[No Abstract] [Full Text] [Related]
26. Modification of dopaminergic receptor sensitivity in rat brain after amygdaloid kindling.
Gee KW; Hollinger MA; Bowyer JF; Killam EK
Exp Neurol; 1979 Dec; 66(3):771-7. PubMed ID: 488251
[No Abstract] [Full Text] [Related]
27. Photoincorporation of [3H]-chloropromazine into a solubilized bovine striatal preparation.
Thermos K; Murphy RB; Schuster DI
Biochem Biophys Res Commun; 1982 Jun; 106(4):1469-77. PubMed ID: 7115414
[No Abstract] [Full Text] [Related]
28. Human brain receptors,V. Binding and message.
Meador-Woodruff JH; Watson SJ; Tamminga CA
Am J Psychiatry; 1994 Jun; 151(6):804. PubMed ID: 8184989
[No Abstract] [Full Text] [Related]
29. [In vivo binding of tritiated agents in mouse brain].
Baudry M; Martres MP; le Sellin M; Guyon A; Morgat JL; Schwartz JC
C R Acad Hebd Seances Acad Sci D; 1977 Oct; 285(9):1001-4. PubMed ID: 411593
[No Abstract] [Full Text] [Related]
30. Absence of 3-methoxy-4-hydroxyphenylethanol in brain.
Wilk S; Zimmerberg B
Biochem Pharmacol; 1973 Mar; 22(5):623-8. PubMed ID: 4692171
[No Abstract] [Full Text] [Related]
31. On the use of protein turnover and half-lives.
Kuhar MJ
Neuropsychopharmacology; 2009 Apr; 34(5):1172-3. PubMed ID: 18923400
[No Abstract] [Full Text] [Related]
32. Effect of AL 721, a novel membrane fluidizer, on the binding parameters of brain dopamine receptors.
Antonian L; Lippa AS
Ann N Y Acad Sci; 1988; 515():403-10. PubMed ID: 3364897
[No Abstract] [Full Text] [Related]
33. Three classes of dopamine receptor (D-2, D-3, D-4) identified by binding studies with 3H-apomorphine and 3H-domperidone.
Sokoloff P; Martres MP; Schwartz JC
Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(2):89-102. PubMed ID: 7207647
[No Abstract] [Full Text] [Related]
34. Guanine nucleotides do not inhibit tritiated dopamine agonist binding to bovine striatal membranes.
Near JA; Mahler HR
Neurochem Res; 1982 Jul; 7(7):831-7. PubMed ID: 7121724
[TBL] [Abstract][Full Text] [Related]
35. Multiple daily amphetamine administration decreases both [3H]agonist and [3H]antagonist dopamine receptor binding.
Sibley DR; Weinberger S; Segal DS; Creese I
Experientia; 1982 Oct; 38(10):1224-5. PubMed ID: 6890464
[No Abstract] [Full Text] [Related]
36. Differential anatomical location of [3H]-N,n-propylnorapomorphine and [3H]-spiperone binding sites in the striatum and substantia nigra of the rat.
Hall MD; Jenner P; Kelly E; Marsden CD
Br J Pharmacol; 1983 Jun; 79(2):599-610. PubMed ID: 6418246
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological characterization of the receptors involved in the apomorphine-induced polyphasic modifications of locomotor activity in mice.
Protais P; Bonnet JJ; Costentin J
Psychopharmacology (Berl); 1983; 81(2):126-34. PubMed ID: 6138794
[TBL] [Abstract][Full Text] [Related]
38. High affinity dopamine receptors (D3) in rat brain.
Titeler M; List S; Seeman P
Commun Psychopharmacol; 1979; 3(6):411-20. PubMed ID: 546589
[No Abstract] [Full Text] [Related]
39. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
Leff SE; Creese I
Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
[TBL] [Abstract][Full Text] [Related]
40. High affinity binding for pramipexole, a dopamine D3 receptor ligand, in rat striatum.
Piercey MF; Walker EL; Feldpausch DL; Camacho-Ochoa M
Neurosci Lett; 1996 Nov; 219(2):138-40. PubMed ID: 8971799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
